Forbion is a leading venture capital firm that works closely with entrepreneurs to build life sciences companies with technologies and products designed to transform people’s lives. Forbion currently manages over €1bn across 10 closed-end funds, and has a team of 13 investment professionals across two offices in The Netherlands and Germany. Forbion’s investment team has built an impressive performance track-record since the late 90s with successful investments in over 50 companies. Forbion helps companies to bridge R&D through the team’s expertise in drug development and company building. Forbion is a signatory to the United Nations Principles for Responsible Investment. Besides financial objectives, Forbion selects investments that will positively affect health and wellbeing of patients.
IP Group is a leading intellectual property commercialization company, which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas – and the resulting businesses – by providing access to business-building expertise, capital (through its 100%-owned, FCA-authorized subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment, and business support.
NeoMed is an international venture capital firm that has been supporting entrepreneurs and businesses in healthcare since 1997. Neomed invests in companies developing innovative and proprietary medical products that address substantial market opportunities in the pharmaceutical and medical device industries.
V-Bio Ventures finds, builds, and finances innovative life sciences companies. V-Bio works closely with Belgium-based VIB, one of the world’s premier life science institutes. V-Bio invests throughout Europe in start-up and early stage companies with high growth potential as well as in technologies that provide transformational improvements in biopharmaceutical, pharmaceutical, and diagnostics markets.
